From Scaffold to Selectivity-Medicinal insights of PRMT1 and PRMT4 inhibitors for Epigenetic Cancer Therapy

Puntos clave

• This research aims to explore the role of PRMT1 and PRMT4 inhibitors in epigenetic cancer therapy and their effects on gene regulation.
• Examined the mechanisms of PRMT1 and PRMT4 in regulating epigenetic modifications.
• Evaluated the therapeutic potential of specific inhibitors targeting these proteins in cancer models.
• Inhibition of PRMT1 and PRMT4 significantly altered gene expression profiles related to cancer progression.
• Observed improved outcomes in cancer models treated with PRMT inhibitors, suggesting enhanced therapeutic efficacy.